Taking these points into consideration and to overcome the limitations of NQ-DCP, we developed a physiologically stable new NQO1 activatable ‘turn-on’ near-infrared fluorescent probe (NIR-ASM) for monitoring endogenous NQO1 activity and noninvasive cancer diagnosis (Fig. 1). Here, NQO1 is linked to cancer.